GLP-1 and gene therapy breakthroughs, plus a drug shortage warning.
May 6, 2026

1. The next phase of the GLP-1 boom Full story

2. FDA approves new Alzheimer's agitation treatment Full story

3. Advocate Health, Mayo Clinic and 515+ speakers at Becker's Health IT event — apply to be a reviewer here

 

4. Mark Cuban's healthcare playbook, explained Full story

5. FDA approves insulin biosimilar, freeing pharmacists to substitute Full story

6. Cancer screening is evolving beyond one-size-fits-all. How leaders are personalizing early detection strategies here.

 

7. FDA approves 1st gene therapy for genetic hearing loss Full story

8. US drug shortages trending upward in 2026 Full story

Becker's Learning Opportunities

9. OHSU and NewYork-Presbyterian replaced fragmented pathways with structured care. Learn how here.

10. How Henry Ford Health improved stewardship and reduced CLABSI rates. Read here.

11. FY 2028 reimbursement could be shaped by an emerging clinical measure. Get the details here.

12. Becker's resources don't stop here — explore more webinars

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication